Industry
Drug Manufacturers - Specialty & Generic
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ER for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment. The company was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. Collegium Pharmaceutical, Inc. was incorporated in 2002 and is headquartered in Stoughton, Massachusetts.
Loading...
Open
N/A
Mkt cap
N/A
Volume
N/A
High
N/A
P/E Ratio
N/A
52-wk high
N/A
Low
N/A
Div yield
N/A
52-wk low
N/A
Portfolio Pulse from Benzinga Newsdesk
July 30, 2024 | 9:47 am
Portfolio Pulse from Benzinga Newsdesk
July 29, 2024 | 10:08 am
Portfolio Pulse from Benzinga Newsdesk
June 13, 2024 | 12:05 pm
Portfolio Pulse from Benzinga Newsdesk
June 07, 2024 | 4:55 pm
Portfolio Pulse from Benzinga Newsdesk
May 13, 2024 | 12:18 pm
Portfolio Pulse from Benzinga Newsdesk
May 10, 2024 | 3:48 pm
Portfolio Pulse from Benzinga Insights
May 10, 2024 | 2:01 pm
Portfolio Pulse from Benzinga Newsdesk
May 10, 2024 | 11:43 am
Portfolio Pulse from Benzinga Newsdesk
May 10, 2024 | 9:25 am
Portfolio Pulse from Benzinga Newsdesk
May 09, 2024 | 9:13 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.